I just read about another case where a pharmaceutical company bought the rights to an old, been-around-forever drug and then drastically increased the price. Argh.
A few months ago I posted about the drug Daraprim, which was bought by Turing Pharmaceuticals. Its CEO, the now infamous Martin Shkreli, raised the price from $13 a pill to over $700.
Last February, Valeant Pharmaceuticals bought the rights to Seconal (secobarbital), an 80-year-old sleeping pill. Ten years ago 90 Seconal tablets cost about 30 dollars. Now it’s closer to $3,000.
It’s believed Valeant did this in response to California’s new End … Continue reading
I recently read an article about a man who was taken to the ER in an ambulance for a sprained wrist.
And then he was astounded when the ambulance company charged him $250!
“If I wanted to go to the emergency room, I could have taken a cab costing less than $10,” he said.
Or Uber. Or a friend. He learned the expensive way that ambulances are costly—$250 is actually on the cheap end—and should not be used without good cause.
Ambulance costs can range anywhere from a couple hundred dollars to well over $2,000, depending on the length … Continue reading
Just yesterday I posted about the United States Preventive Services Task Force (USPSTF) and the fine line they walk between providing evidence-based recommendations for screening tests and making medical specialist groups happy.
Sometimes it just doesn’t happen.
The task force recently gave an “I” grade to vision screening in patients over 65. An I grade, or Insufficient evidence, means that the task force can’t definitively say that the benefits of vision screening in older adults outweigh the possible harms.
The American Academy of Ophthalmology (AAO) doesn’t agree.
Specifically, the task force reviewed the evidence for primary care doctors screening for … Continue reading
One of the driving forces behind rising health care costs is the increasingly high cost of prescription drugs.
And because 60% of Americans take at least one prescription drug, that adds up to a lot of money.
Insurance companies are trying to rein in costs by having tiered copayments (higher for brand names) or limiting the selection of drugs on their formularies (the list of drugs your insurance will cover).
This post gives you some suggestions to save money, and some resources that might be helpful.
But first, ask yourself and your physician if a prescription drug is really … Continue reading
Last November, with much media coverage, several members of Congress announced the formation of The Affordable Drug Pricing Task Force, promising to “take action to combat the skyrocketing costs of pharmaceuticals.”
Finally! I thought.
Related post: Prices continue to increase for generics
But I haven’t heard much since then.
There was a little noise earlier this month when the House Oversight Committee (of which the task force is a subcommittee, I believe) attempted to grill the now infamous Martin Shkreli about why he thought it was okay to jack up the price of Daraprim from $13 a pill to … Continue reading
The Advisory Committee for Immunization Practices (ACIP) and the Centers for Disease Control (CDC) have just released an updated vaccination schedule for adults.
I’ve included the schedule and accompanying information from the CDC’s website at the end of this post.
You can also print it out to take to your primary care provider.
Related post: Adults need vaccinations, too!
It’s color coded to make it easier to follow the recommendations, and I think it’s an improvement over last year’s chart.
A yellow row/column means the vaccine is recommended for everybody in that age group; purple indicates the vaccine is for … Continue reading
We’ve all heard the phrase “cancer kills.”
But guess what? So can the high cost of treatment.
I just read about a study that came out of the Fred Hutchison Cancer Research Center here in Seattle.
The results won’t surprise anyone familiar with how much cancer treatment costs (a lot!), but researchers found:
…cancer patients who go bankrupt are nearly 80 percent more likely to die than patients who don’t, and some cancers had significantly higher mortality rates. Prostate cancer patients who filed for bankruptcy were almost twice as likely to die; bankrupt colorectal cancer patients were 2.5 times more
… Continue reading
I read two articles yesterday that complemented each other:
In Kaiser Health News (KHN) Heavy Use Of CT Scans Raises Concerns About Patients’ Exposure To Radiation
And on KevinMD two radiologists posted The financial costs of treating CT-induced cancer
Each underscores the fact that CT scans are significantly overused in American healthcare.
Although CT scans are an essential diagnostic tool, the Food and Drug Administration reports that an estimated 30 to 50 percent of imaging tests are believed to be medically unnecessary.
Considering we spend tens of billions of dollars every year on diagnostic imaging, that’s a lot of wasted … Continue reading
Keeping our money and personal information safe from hackers is an ever-present, and ever-expanding, problem.
Most big retailers and financial institutions are fighting back and making it more difficult for hackers to get our personal and credit info. That’s great, but unfortunately the hackers are just moving to an easier target—our medical identities.
Medical data breaches are expected to be a big problem in 2016.
Medical information is in shorter supply, so hackers can sell it for more. Plus, most people now know to keep an eye on their credit and bank statements for signs of fraud. However, few people
… Continue reading
The health care blog KevinMD is a great place to read firsthand accounts of how our expensive and fragmented health care system really works (or doesn’t).
Last week I read a post by a physician who described his friend’s experience of trying to get treated for an ordinary but painful kidney stone. (I’ve never had one, but I’ve been told they are extremely painful!)
Sadly, his friend had a narrow-network insurance plan and he wasn’t able to find either an in-network specialist—urologist—or the specialized treatment that would alleviate his pain.
So here was Jeremy, an insured, otherwise healthy patient in
… Continue reading